Popular Articles

Data Presented At The 5th International AIDS Society Conference Suggests Low Testosterone Frequently Goes Undetected In HIV-Positive Men
Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a specialty biopharmaceutical company, announced that new data from the two-part HYHYHI Study (Hypogonadal Hypotestosteronism in HIV-Seropositive Men) were presented as a poster today at the 5th International AIDS Society (IAS) Conference in Cape Town, South Africa. This retrospective chart review, supported by the Company, evaluated the challenges associated with diagnosing low testosterone in men with HIV/AIDS. The study also compared the difference in testosterone levels achieved after 12 months of treatment with either Testim® 1% (testosterone gel) or AndroGel®, two commonly used FDA-approved testosterone replacement products.
generic viagra online
ABPI Viewpoint: The Price Of Medicines, UK
According to the Department of Health, for every ÷£1 spent on healthcare in the UK, just 12p goes on medicines. Yet when it comes to debate around
News of the day
Fighting Human Trafficking By Genetic Identification
DNA-Prokids (http://www.dna-prokids.org), an international project on human trafficking prevention and fight using genetic identification of victims and their relatives, was officially presented, at the University of Granada (UGR) headquarters, in Spain.
Diagnostics

Leading Medical Organizations Issue Revised Policy Statement On Learning Disabilities And Dyslexia

The American Academy of Ophthalmology announced that it has issued a revised policy statement on Learning Disabilities, Dyslexia, and Vision. The revised statement, which was issued jointly with the American Academy of Pediatrics (AAP), the American Association for Pediatric Ophthalmology and Strabismus (AAPOS) and the American Association of Certified Orthoptists (AACO), expands upon the previous policy and includes extensive scientific references. The statement was also published today in Pediatrics, the journal of the AAP. "Dyslexia and learning disabilities are complex problems that have no simple solutions," said Sheryl Handler, M.D., a pediatric ophthalmologist who helped revise the statement. "This policy statement applies the available evidence to develop recommended steps for the best possible outcome for children with these disabilities. We hope that the statement will be helpful for the physicians who play an important role in the care of children with learning disabilities." Learning disabilities affect an estimated 2.6 million children between the ages of 6 to 11. Approximately 80 percent of people with learning disabilities have dyslexia, a primary reading disorder that is language-based. It is an abnormality in the word analysis pathways of the brain that interferes with its ability to convert written words into spoken words. Early identification and referral to qualified professionals are essential. Children with learning disabilities should receive individualized, evidence-based educational interventions combined with psychological and medical treatments as needed. "Currently, there is no adequate scientific evidence to support the view that subtle eye or visual problems cause learning disabilities," the policy states. Numerous studies have shown that children with dyslexia or related learning disabilities have the same visual function and ocular health as children without such conditions," the statement notes. "Specifically, subtle eye or visual problemṣ€¦do not cause dyslexia. In summary, research has shown that most reading disabilities are not caused by altered visual function." The statement also notes that there is no scientific evidence to support the use of vision therapy or tinted lenses or filters as effective direct or indirect treatments for learning disabilities. There is no valid evidence that children participating in vision therapy are more responsive to educational instruction than children who do not participate. "The claim that vision therapy improves visual efficiency cannot be substantiated," the policy states. "Diagnostic treatment and approaches that lack scientific evidence of efficacy are not endorsed or recommended." The policy statement is available here. More information about vision therapy for learning disabilities is available here. American Academy of Ophthalmology


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):